CytomX Therapeutics CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform. | SQZ Biotech SQZ Biotechnologies is a company that develops cell therapies for patients with cancer and infectious diseases. | Ajinomoto Bio-Pharma Services Ajinomoto Bio-Pharma Services (formerly known as Ajinomoto Althea) is a contract development and manufacturing organization (CDMO). | |
Founding Date | Founding Date 2008 | Founding Date 2013 | Founding Date 1998 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations South San Francisco, US HQ | Locations Watertown, US HQ | Locations San Diego, US HQ Wetteren, BE Visakhapatnam, IN Osaka, JP |
Employees | Employees 15815% increase | Employees 5353% decrease | Employees 7811% increase |
Valuation ($) | Valuation ($) 84.4 m | Valuation ($) 12.8 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $101.2m (FY, 2023) | Revenue (est.) $21.5m (FY, 2022) | Revenue (est.) N/A |
Net income | Net income ($569k) (FY, 2023) | Net income ($79.5m) (FY, 2022) | Net income N/A |
Operating ⚠ | |||
Phase I Trials Products | Phase I Trials Products 1 (FY, 2016) | Phase I Trials Products 1 (Q2, 2020) | Phase I Trials Products N/A |
Pre-Clinical Phase Products | Pre-Clinical Phase Products 4 (FY, 2016) | Pre-Clinical Phase Products 10 (Q2, 2020) | Pre-Clinical Phase Products N/A |
Funding | |||
Total funding raised | Total funding raised $ 132.4m | Total funding raised $ 233.4m | Total funding raised $ 3.5m |